 |
|
Risk of Mortality by Histologic Type of Breast Cancer Among Women Aged 50 to 79 Years
Christopher I. Li, MD, PhD;
Roger E. Moe, MD;
Janet R. Daling, PhD
Arch Intern Med. 2003;163:2149-2153.
Background Recent studies suggest that the use of combined estrogen and progestin hormone replacement therapy is associated with an increased risk of invasive lobular carcinoma (ILC), but that it has little association with risk of invasive ductal carcinoma (IDC). Also, the incidence rates of ILC have risen over the past 10 years while those of IDC have remained constant. Differences in survival rates by histologic types of tumor have been reported, but few of the published studies were population based or had adequate power to address this issue.
Methods We conducted a retrospective cohort study spanning the years 1974 through 1998 using data from the 9 cancer registries that have participated in the Surveillance, Epidemiology, and End Results Program since 1974. The cohort consisted of 164 958 women aged 50 to 79 years who had been diagnosed as having 1 of 7 histologic types of invasive breast cancer. Risks of mortality due to any cause were estimated using the Cox proportional hazards model.
Results Women with ILC had a risk of mortality 11% lower than women with IDC. The magnitude of this difference has increased over the past 10 years and, from 1994 through 1998, the risk of mortality was 26% lower for women with ILC. Also, the risk of mortality was between 8% and 34% lower in women with mucinous carcinoma, comedocarcinoma, or medullary, tubular, and papillary carcinomas compared with women with IDC.
Conclusions Differences in prognosis by histologic type of breast cancer were identified. The survival rate of women 50 to 79 years old who have ILC, the cancer whose histologic type is the most closely linked with the use of combined estrogen and progestin hormone replacement therapy, is more favorable than that of women with IDC and appears to be improving over time.
From the Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Wash (Drs Li and Daling), and the Department of Surgery, School of Medicine, University of Washington, Seattle (Dr Moe). The authors have no relevant financial interest in this article.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population
Vona-Davis et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:3319-3324.
ABSTRACT
| FULL TEXT
Tumor Metabolism and Blood Flow Changes by Positron Emission Tomography: Relation to Survival in Patients Treated With Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
Dunnwald et al.
JCO 2008;26:4449-4457.
ABSTRACT
| FULL TEXT
Timing of Menarche and First Full-Term Birth in Relation to Breast Cancer Risk
Li et al.
Am J Epidemiol 2008;167:230-239.
ABSTRACT
| FULL TEXT
Relationship between Menopausal Hormone Therapy and Risk of Ductal, Lobular, and Ductal-Lobular Breast Carcinomas
Li et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:43-50.
ABSTRACT
| FULL TEXT
Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment
Biglia et al.
Endocr Relat Cancer 2007;14:549-567.
ABSTRACT
| FULL TEXT
Postmastectomy Radiation and Survival in Older Women With Breast Cancer
Smith et al.
JCO 2006;24:4901-4907.
ABSTRACT
| FULL TEXT
Relationship between Established Breast Cancer Risk Factors and Risk of Seven Different Histologic Types of Invasive Breast Cancer.
Li et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:946-954.
ABSTRACT
| FULL TEXT
|
